561 related articles for article (PubMed ID: 32140917)
1. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
2. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
[TBL] [Abstract][Full Text] [Related]
3. The effect of pharmaceutical companies' marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study.
Al Thabbah DH; Almahairah MS; Naser AY; Alrawashdeh HM; Araidah M
BMC Health Serv Res; 2022 Oct; 22(1):1293. PubMed ID: 36303214
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
5. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
Caudill TS; Johnson MS; Rich EC; McKinney WP
Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
[TBL] [Abstract][Full Text] [Related]
6. Report: Interactions and conflicts of interests between prescribers and medical sales representatives (MSRs) regarding prescribing and drug promotion practices in Karachi, Pakistan.
Naqvi AA; Zehra F; Khan N; Ahmad R; McGarry K
Pak J Pharm Sci; 2019 Mar; 32(2):687-695. PubMed ID: 31081784
[TBL] [Abstract][Full Text] [Related]
7. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
[TBL] [Abstract][Full Text] [Related]
8. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
[TBL] [Abstract][Full Text] [Related]
9. What patients think about promotional activities of pharmaceutical companies in Turkey.
Semin S; Güldal D; Ozçakar N; Mevsim V
Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
[TBL] [Abstract][Full Text] [Related]
10. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design.
Hailu AD; Workneh BD; Kahissay MH
BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248
[TBL] [Abstract][Full Text] [Related]
11. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
Spurling GK; Mansfield PR; Montgomery BD; Lexchin J; Doust J; Othman N; Vitry AI
PLoS Med; 2010 Oct; 7(10):e1000352. PubMed ID: 20976098
[TBL] [Abstract][Full Text] [Related]
12. Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia.
Workneh BD; Gebrehiwot MG; Bayo TA; Gidey MT; Belay YB; Tesfaye DM; Kassa TT
PLoS One; 2016; 11(6):e0156795. PubMed ID: 27304215
[TBL] [Abstract][Full Text] [Related]
13. Physicians' perceptions of medical representative visits in Yemen: a qualitative study.
Al-Areefi MA; Hassali MA; Ibrahim MI
BMC Health Serv Res; 2013 Aug; 13():331. PubMed ID: 23962304
[TBL] [Abstract][Full Text] [Related]
14. Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
Jandhyala R
Pharmaceut Med; 2020 Apr; 34(2):127-134. PubMed ID: 32048216
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
[TBL] [Abstract][Full Text] [Related]
16. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
17. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.
Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P
PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484
[TBL] [Abstract][Full Text] [Related]
18. Attitudes and behaviours of physicians towards the relationship with the pharmaceutical industry in Saudi Arabia.
Bahammam S; Asiri S; Al-Jahdali Y; Baharoon S; Al Shaikh A; Al-Ghamdi M; ALharbi A; Al-Jahdali H
East Mediterr Health J; 2020 Mar; 26(3):323-330. PubMed ID: 32281642
[TBL] [Abstract][Full Text] [Related]
19. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
20. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
